| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |